JCV Antibody Program (STRATIFY-1)



Status:Archived
Conditions:Neurology, Multiple Sclerosis
Therapuetic Areas:Neurology, Other
Healthy:No
Age Range:Any
Updated:7/1/2011
Start Date:March 2010
End Date:August 2012

Use our guide to learn which trials are right for you!

JCV Antibody Program in Patients With Relapsing Multiple Sclerosis Receiving or Considering Treatment With Tysabri: STRATIFY-1


Study conducted to define the prevalence of Serum JC Antibody in relapsing MS patients
receiving Tysabri or being considered for such treatment.

Analytically validate the JCV antibody assay in a plasma matrix.


This study requires blood and urine collection @ enrollment and every 6 months thereafter
for up two years.


We found this trial at
10
sites
570
mi
from 91732
Salt Lake City, UT
Click here to add this to my saved trials
2002
mi
from 91732
Asheville, NC
Click here to add this to my saved trials
1919
mi
from 91732
Atlanta, GA
Click here to add this to my saved trials
2550
mi
from 91732
Ayer, MA
Click here to add this to my saved trials
1665
mi
from 91732
Beloit, WI
Click here to add this to my saved trials
712
mi
from 91732
Bend, OR
Click here to add this to my saved trials
817
mi
from 91732
Denver, CO
Click here to add this to my saved trials
1966
mi
from 91732
Detroit, MI
Click here to add this to my saved trials
1728
mi
from 91732
Evanston, IL
Click here to add this to my saved trials
1357
mi
from 91732
Houston, TX
Click here to add this to my saved trials